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Abstract
Due to policies that penalize hospitals for chronic obstructive pulmonary disease (COPD)
readmissions and the health problems faced by individuals who are readmitted due to
COPD, it is critical to identify treatments and strategies that can help reduce the
likelihood of readmission. The purpose of this study was to assess the association of
pulmonary rehabilitation and demographic variables (age, gender, and BMI) on 30-day
hospital readmissions for patients with COPD. Shearer’s health empowerment theory was
the theoretical framework for this quantitative study. Secondary data were obtained from
a hospital and the sample was comprised of 253 COPD patients admitted between 2017
and 2019. Linear and multiple regression was used to analyze each research question.
The results indicated age, gender, BMI, and pulmonary rehabilitation did not influence
the readmission rate of COPD patients. These findings suggest less emphasis be placed
on age, gender, BMI, and pulmonary rehabilitation when dealing with COPD
readmissions. The results of this study provide information to healthcare organizations
and patients with COPD around the use of pulmonary rehabilitation. Hospitals can invest
in other methods of COPD treatment by developing various programs to lower hospital
readmissions, reduce healthcare costs, and improve the quality of life for patients with
COPD while contributing to a positive social change.
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Chapter 1: Introduction to the Study
Introduction
Pulmonary rehabilitation is a promising treatment for individuals suffering from
Chronic Obstructive Pulmonary Disease (COPD); this treatment includes physical and
dietary components, among others. Due to policies that penalize hospitals for COPD
readmissions and the health problems faced by individuals who are readmitted due to
COPD, it is critical to identify treatments and strategies that can help reduce the
likelihood of readmission. Currently, there is a lack of research comparing the
readmission rates of individuals with COPD that complete pulmonary rehabilitation
compared to those who do not. I examined the benefits of pulmonary rehabilitation on
hospital readmissions for patients with COPD. The study was guided by Shearer’s (2009)
health empowerment theory. The health empowerment theory refers to the process of
individuals purposefully participating in changing their environment and self-change,
where individuals can engage the resources available to them and recognize avenues for
the best well-being (Shearer, 2009). Specifically, I first determined whether there was a
difference between readmission rates of COPD patients who participate in 30 days of
pulmonary rehabilitation compared to those who do not participate. Then, I identified
whether there was a relationship between age and 30-day readmission rates for patients
admitted with COPD.
This study has the potential to create positive social change for COPD patients
and hospitals. Furthermore, the results from this study may be able to help identify risk
factors for readmission among COPD patients; in turn, this could ultimately help
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hospitals identify COPD patients that may need outpatient treatment or rehabilitation and
avoid monetary fines for readmission, which benefits both patients and hospital
administration. In Chapter 1, I outline the research gap, problem, and significance for this
study. I also present the research questions and describes the theoretical framework used
to guide the study.
Background
Patients with COPD face many health issues and frequent hospital readmission
(Feemster & Au, 2014). Shah et al. (2015) performed a large study with over 27 million
patients admitted into the hospital; the researchers found 3.5% had COPD and were
readmitted within 30 days post discharge with unknown reasoning. Common factors
related to readmission for COPD patients include a longer length of stay, older age,
comorbidity, and COPD complexity (Candrilli et al., 2015). Additionally, Kim et al.
(2016) related nursing staffing levels to COPD readmissions and found that there was a
significant correlation between staffing and readmissions where fewer staff was
indicative of greater readmissions. The researchers also concluded that there is a need to
provide patient education about COPD protective and risk factors, prior to being
discharged from the hospital (Kim et al., 2016).
There are many benefits of pulmonary rehabilitation. Alshabanat et al. (2017)
developed a comprehensive case management plan for COPD patients, which was
implemented and shown to decrease hospitalizations by 30% and decrease readmissions
from 30.2% to 15.7%. Kargiannakis et al. (2017) utilized telehealth medicine to patients
discharged from the hospital with a COPD exacerbation. This intervention was effective,
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in that it reduced readmissions from 20% down to 9%. Casaburi (2018) also suggested
that benefits of pulmonary rehabilitation for COPD patients include improvements in
exercise tolerance, dyspnea, and quality of life. Other research by McCarthy et al. (2015)
showed that pulmonary rehabilitation was related to decreased dyspnea and fatigue,
greater emotional function, and greater feelings of control over patients’ COPD
condition. There is still a gap in the literature, however, regarding pulmonary
rehabilitation’s impact on COPD readmissions.
This research is needed because pulmonary rehabilitation may benefit COPD
patients, but it may or may not be a key factor in COPD readmissions; if it is not related
to COPD readmissions, additional research is needed to identify treatments that can help
to reduce COPD readmissions. Casaburi (2018) cited that pulmonary rehabilitation is
only offered to a small percentage of COPD patients. This is problematic because
pulmonary rehabilitation could potentially decrease readmissions. Additionally, COPD
readmission is critical to study because it can be costly to the hospitals and indicate poor
health of the patient (Crisafulli et al., 2008; Pruitt, 2018). Pruitt discussed the loss of
Centers for Medicare and Medicaid Services (CMS) reimbursement as a result of COPD
readmissions, which can then negatively impact hospitals, particularly those with narrow
profit margins. There is a need to improve care and reduce readmissions (Pruitt, 2018).
Additionally, studying readmissions of COPD patients is particularly important because
COPD patients tend to have comorbid conditions, such as congestive heart failure (CHF)
and metabolic disease (Crisafulli et al., 2008). In one study, the researchers found that
over half (51%) of COPD patients who were going through pulmonary rehabilitation had

4
at least one other chronic disease, with metabolic disease and heart disease being the two
most common comorbidities (Crisafulli et al., 2008). The lack of understanding regarding
factors impacting COPD readmissions among pulmonary rehabilitation patients is
significant because COPD is a leading cause of both hospitalizations and hospital
readmissions in the United States (Baker et al., 2013).
Problem Statement
In 2017, CMS implemented the Hospital Readmission Reduction Program (Lau et
al., 2017). This includes financial penalties for readmissions among patients with COPD
(Rinne et al., 2017). Readmission penalties result from any COPD patient who is
readmitted within 30 days of being discharged (Feemster & Au, 2014). Feemster and Au
(2014) explained that in October 2014, Medicare and Medicaid began to restrict
payments to hospitals for patients with COPD if they were readmitted within 30 days
postdischarge. More than 2,000 hospitals paid a total of $280 million in penalties for the
fiscal year 2013 (Feemster & Au, 2014).
Presently, in the United States, 2 million emergency room (ER) visits are
associated with COPD exacerbations, with over 700,000 admissions annually, costing
approximately $60 billion (Feemster & Au, 2014). Of the 700,000 admissions in the
United States annually, 22.6% have a readmission within the 30-day period (Feemster &
Au, 2014). COPD patients are at a further disadvantage because a major complication
faced by COPD patients is comorbidity with other diseases, increasing the likelihood of
readmission and poorer health outcomes among these patients (Crisafulli et al., 2008).
According to Rinne et al. (2017), hospitals were estimated to be penalized more than
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$500 million in 2017 due to these readmission policies. Furthermore, there is a need to
improve care and reduce readmission rates for COPD patients after they are discharged
from the hospital (Pruitt, 2018).
Although more research on pulmonary rehabilitation is needed, its impact on
patients’ health is promising. Pulmonary rehabilitation can be used to prevent
readmissions in patients with COPD and is considered an intensive service that can
include behavior change, education, and exercise (Postolache et al., 2015). The purpose
of pulmonary rehabilitation is to improve the physical and emotional burdens faced by
patients with respiratory diseases so they can experience long-term health improvements
(Maddocks et al., 2016; Postolache et al., 2015). Length of pulmonary rehabilitation can
vary from 4 to over 50 weeks but is typically between 8 and 12 weeks (Maddocks et al.,
2016; McCarthy et al., 2015). In addition, researchers have indicated that comorbidities
in COPD patients going through pulmonary rehabilitation may impact the quality of life
(Crisafulli et al., 2008). Further quantitative research is needed in order to understand
whether comorbidities impact the likelihood of readmission for these patients. Scholars
have suggested that age may play a role in readmission rates of COPD patients in the
inpatient setting (Candrilli et al., 2015), but it is unknown whether age is correlated with
readmission rates for COPD patients that participate in a pulmonary rehabilitation
program. The lack of understanding regarding factors impacting COPD readmissions
among pulmonary rehabilitation patients is significant because COPD continues to be a
concern for hospital readmissions and pulmonary rehabilitation is a widely used method
of treatment for COPD patients (e.g., Apps et al., 2016; Rochester et al., 2015). The
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concern is that pulmonary rehabilitation is not being administered on a regular basis for
COPD patients following discharge from the hospital. The lack of usage is problematic
because of the likelihood of COPD-related readmissions and other risk factors related to
COPD.
Purpose of the Study
The purpose of this quantitative study was to examine the benefits of pulmonary
rehabilitation on hospital readmissions for COPD patients. To do this, 30-day
readmissions for COPD patients who completed a pulmonary rehabilitation program were
compared to those who did not complete a pulmonary rehabilitation program. Age and
other relevant demographics—such as gender, weight, BMI, and other health
conditions—were included in the analysis to determine their impact on the likelihood of
readmission. The American Thoracic Society and European Respiratory Society have
defined pulmonary rehabilitation as a comprehensive intervention that involves a
thorough patient assessment and patient-tailored therapies (Man et al., 2015). Pulmonary
rehabilitation can involve exercise training, education, and behavior changes, designed to
improve the physical and psychological conditions of people with chronic respiratory
disease (Man et al., 2015). There is a significant need to research COPD to identify
factors that could reduce readmissions because of the penalties being assessed to
hospitals and identify opportunities to impact COPD readmissions.
Research Questions and Hypotheses
Overall, the primary focus of this study was to identify whether the length of
pulmonary rehabilitation treatment is significantly related to hospital readmission for
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COPD patients. Furthermore, because age may impact treatment and care received
(Candrilli et al., 2015), I also examined whether age is significantly related to hospital
readmission for COPD patients at McLaren Lapeer Regional Medical Center in
Michigan. Demographic variables such as gender and BMI were statistically controlled
for if they were associated with the predictor or criterion variables. The guiding research
questions and their associated hypotheses were as follows:
Research Question 1: Is there a difference between readmission rates of patients
with COPD who participate in 6 weeks of pulmonary rehabilitation compared to those
who do not?
H10: There is no difference in the readmission rates of patients with COPD who
participate in at least 6 weeks of pulmonary rehabilitation compared to those who
do not.
H1a: There is a difference in the readmission rates of patients with COPD who
participate in at least 6 weeks of pulmonary rehabilitation compared to those who
do not.
RQ2: Is there a relationship between age and 30-day readmission rates for patients
admitted with COPD?
H20: There is no relationship between age and 30-day readmission rates for
patients admitted with COPD.
H2a: There is a relationship between age and 30-day readmission rates for patients
admitted with COPD.
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Theoretical Framework
I employed Shearer’s (2009) health empowerment theory to guide this study. This
theory describes how patients use personal and social resources to enhance their wellbeing. Health empowerment theory involves the integration of personal resources as well
as social-contextual resources (Shearer, 2009). Additionally, it involves the process of
individuals purposefully participating in self-change and changing their environment by
utilizing the resources available to them (Shearer, 2009).
Addressing factors that impact patients’ likelihood of readmission can also help to
identify ways to empower patients, thus improving their health and reducing the risk of
readmission. For instance, if older patients are shown to be more likely to be readmitted,
this could highlight the importance of empowerment interventions to those patients,
resulting in them taking a more prominent role in their own health and being less likely
be hospitalized. If patients who are more at risk and are more in need of empowerment
interventions can be identified, the patients’ health outcomes may improve, and hospitals
may be able to save money. Empowerment has been shown to be critical for reducing
length of stay and readmission rates (Gonya et al., 2014), improving mental health and
coping outcomes (Melnyk et al., 2004), and increasing self-efficacy among patients
(Kashani et al., 2015). Gonya et al. (2014) worked with parents of premature infants,
finding that parent empowerment reduced the length of stay for these infants and
decreased their readmission rates. Additionally, Melnyk et al. (2004) worked to evaluate
an empowerment program that targeted parents of critically ill young children; this
program was shown to decrease stress, improve mental health (including depression), and
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increase parent participation in their child’s treatment. Moreover, pulmonary
rehabilitation may be an empowering treatment for COPD patients; therefore, the
empowerment theory guided this study.
The importance of empowerment has been demonstrated among COPD patients’
health outcomes as well. Specifically, empowerment has been shown to increase the selfefficacy of COPD patients (Ansari et al., 2017), help COPD patients live optimally and
feel more in control (Fotoukian et al., 2017), and help COPD patients succeed in
pulmonary rehabilitation (Meis et al., 2014). Ansari et al. (2017) highlighted the need for
COPD patients to be educated on COPD risks and treatments because self-management
was an empowering way to increase self-efficacy. Fotoukian et al. (2017) found that
empowerment was critical for COPD patients to manage their life with their disease and
helped them to live optimally. Meis et al. (2014) studied the empowering impact of
pulmonary rehabilitation; after conducting interviews and focus groups, the researchers
found that pulmonary rehabilitation helped patients to succeed during the treatment.
Specifically, patients were able to focus on the positives and better accept their COPD
diagnosis, had increased motivation, and improved exercise abilities (Meis et al., 2014).
This theory can be aligned with the goals of the current study because pulmonary
rehabilitation may help to empower COPD patients. Furthermore, I used the
empowerment theory to examine the impact of pulmonary rehabilitation and age on
hospital readmissions of COPD patients. As Shearer (2009) noted, empowerment is
crucial for treatment of older adults, which was relevant to my evaluation of the role of
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age in COPD patient readmissions. In the next section, I describe the nature of the study
and the rationale behind the use of a quantitative methodology.
Nature of the Study
A quantitative methodology with a cross-sectional design was used for this study.
Quantitative methods were appropriate because this study aimed to identify relationships
between age, patient demographics, and readmission rates among COPD patients in the
pulmonary rehabilitation setting. The key variables in this study were gender, age,
comorbidity rates, length of stay at a pulmonary rehabilitation program, and readmission
rates. This study involved both continuous and categorical data. Additionally, the data in
this study were secondary data. Data were gathered from the Electronic Medical Record
(EMR) from a medical facility.
A staff member from the facility sent the data for this study to me for analysis. All
participant responses and demographics were deidentified; to do this, unique identifiers
were assigned to each participant. The first component of data analysis was descriptive
analyses. This resulted in information related to the means, standard deviations, and
ranges of demographic variables, readmission rates, readmissions fees, and comorbidity
rates. Then, simple regression and multivariate regression were used to address the
study’s research questions, while controlling for potential confounders. In this study, the
primary outcome variable was COPD patient readmission rates. Length of pulmonary
rehabilitation, age, and gender were the predictor variables. SPSS statistical software was
used for all analyses.
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Definitions
Operational definitions are provided below for the key terminology in the current study:
Chronic Obstructive Pulmonary Disease (COPD): This is a group of diseases that
cause airflow blockage and breathing-related problems and includes emphysema and
chronic bronchitis (Centers for Disease Control and Prevention [CDC], 2018).
Pulmonary rehabilitation: This refers to a personalized treatment program that
teaches COPD management strategies to improve quality of life. Pulmonary
rehabilitation is a comprehensive treatment that can include plans that teach people how
to breathe better and conserve their energy, as well as provide advice on food nutrition
and exercise (CDC, 2018).
Comorbid conditions: This term describes presenting with more than condition or
disease; COPD patients tend to have other chronic diseases like arthritis, congestive heart
failure, diabetes, coronary heart disease, stroke, or asthma (CDC, 2018).
Readmissions: In the context of the current study, only COPD-related hospital
readmissions was considered under the readmission variable.
Assumptions
Assumptions are part of all research studies. In the current study, I assumed that
COPD patients had an accurate diagnosis of COPD prior to participation in the current
study; this was necessary because if the diagnoses were not accurate, the impacts of
pulmonary rehabilitation on COPD specifically may not have been relevant or true.
Additionally, I assumed that the pulmonary rehabilitation components were implemented
effectively and that the practitioners tasked with carrying out the treatment did so with
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fidelity; this assumption was necessary because pulmonary rehabilitation completion is
not relevant if it was not implemented effectively. I also assumed that readmissions were
due to the COPD diagnosis; this assumption was necessary because if the readmission is
due to another condition, it is not possible to make claims about pulmonary
rehabilitation’s impact on COPD rehabilitation and the results from this study would be
inconclusive. Last, I assumed that the data in the current study were normally distributed,
because if the data violated assumptions of normality, parametric statistical methods are
not appropriate. This assumption was necessary because if the assumptions of normality
are not met, nonparametric designs for correlation and group differences would have
been used, which would have changed the design slightly, but would not have impacted
the variables or research questions.
Scope and Delimitations
The scope and delimitations involve factors that are of focus for the study and are
in my control. The scope of the current study involved COPD patients from a single
rehabilitation setting; this population was chosen because of the importance of reducing
readmission rates for them in order to benefit the patients themselves and the hospitals
that serve them. As described in the limitations for this study, however, the use of a
single rehabilitation setting may have implications for the generalizability of the results to
other settings. Additionally, this study only included patients diagnosed with COPD, not
those who may have symptoms but lack diagnosis; this was necessary to identify the
impacts of pulmonary rehabilitation on COPD readmissions.
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Limitations
The current study was not without limitations. The first limitation involved the
nonexperimental design, meaning that I was not able to make any causal claims. Instead,
I discussed associations between variables and group differences in the data.
Additionally, I did not evaluate COPD patients from a variety of settings; therefore, the
results from this study may not be generalizable to other geographic locations or other
rehabilitation settings. Specifically, the generalizability of the results obtained from only
one rehabilitation setting in the current study may be limited to similar settings.
Moreover, it is possible that the COPD patients from the single rehabilitation setting may
not be representative of COPD patients from other rehabilitation settings, which posed
another potential limitation for the current study. The implications for the generalizability
of the study results are further described in the discussion of the findings.
Significance of the Study
COPD patients are faced with many challenges, including a high likelihood of
readmission and the likelihood of comorbidities. Many previous scholars have examined
readmission rates among COPD patients (Amin, 2015; Jiang et al., 2017; Tran et al.,
2016; Zhang et al., 2017). The factors related to readmission for COPD patients include
greater amounts of time spent at the hospital prior to readmission, older age,
comorbidities, and COPD complexity (Candrilli et al., 2015). This is important because
comorbid diseases have been shown to predict readmission of COPD patients (Baker et
al., 2013). Furthermore, hospitals currently experience harsh financial penalties resulting
from COPD patient readmissions, making it in the best interest of the patients and
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hospitals to reduce COPD readmissions (Feemster & Au, 2014; Holt, 2013; Rinne et al.,
2017). This study was significant because I examined whether the use of a postdischarge
pulmonary rehabilitation program could significantly impact these fees and could
promote more insurance coverage for these services. The findings of the study may assist
researchers and practitioners in identifying protective and risk factors (including COPD
patients that may be more vulnerable to readmission) for readmission among COPD
patients, which can ultimately help hospitals identify COPD patients who may need
outpatient treatment or rehabilitation, improve the health outcomes of COPD patients,
and avoid monetary fines for readmission.
Summary
Through this study, I aimed to examine the benefits of pulmonary rehabilitation
on hospital readmissions for COPD patients in one facility. The study was guided by
Shearer’s (2009) health empowerment theory, which describes how patients actively
participate in behaviors to change their environment and promote self-change and wellbeing by making efficient use of the resources available to them. The results from this
study may benefit COPD patients by identifying potential risk factors for readmission and
identifying the benefits of pulmonary rehabilitation. Additionally, the results from the
current study may help inform hospitals of the protective and risk factors related to
COPD and COPD readmission. Hospitals may benefit from this because readmission for
COPD patients is very costly for hospitals. The scope, delimitations, assumptions, and
limitations of the study are further addressed in the discussion in Chapter 5. In Chapter 2,
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I review the body of existing literature on this topic in order to better describe the
background of this study and the research gap.
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Chapter 2: Literature Review
Introduction
In the United States, 16 million Americans currently have COPD, and millions of
others suffer from COPD but have not been formally diagnosed or treated (CDC, 2018).
Hospital visits due to COPD-related problems are estimated to cost $60 billion per year
(Feemster & Au, 2014). This is problematic because over 22% of patients with COPD are
readmitted within 30 days of hospital discharge due to COPD-related issues and
comorbid conditions (Crisafulli et al., 2008). Furthermore, comorbid conditions
(Franssen & Rochester, 2014), along with age (CDC, 2018), are factors that could
exacerbate the likelihood of readmission rates of patients with COPD. Previous
researchers have indicated that hospitals are lacking information regarding ways to
minimize COPD readmissions (Shah et al., 2016). In the current study, I evaluated
whether pulmonary rehabilitation may be a beneficial option to decrease COPD
readmission rates.
In this study, I evaluated the benefits of pulmonary rehabilitation on hospital
readmissions for patients with COPD. First, I determined whether there is a difference
between readmission rates of patients with COPD that participate in 30 days of
pulmonary rehabilitation compared to those that do not complete any pulmonary
rehabilitation, while adjusting for potential confounders. I then identified whether there is
a relationship between age and 30-day readmission rates for patients admitted with
COPD, while adjusting for potential confounders. In this chapter, I describe the literature
search strategy and the theoretical framework that guided the study. I then provide a
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description of the literature regarding COPD, pulmonary rehabilitation, readmission rates,
and age.
Literature Search Strategy
I used Google Scholar, PubMed, and ERIC to identify previous studies regarding
key variables and concepts in this study, as well as literature on Shearer’s (2009) health
empowerment theory, which is described in more detail in the next section. Key search
terms included the following: COPD, COPD readmission, Shearer’s health
empowerment theory, COPD AND age, COPD AND comorbid diagnoses, COPD
readmission reasons, COPD readmission AND risk factors, predictors of COPD
readmission, reducing COPD readmissions rates, pulmonary rehabilitation, pulmonary
rehabilitation benefits, COPD AND pulmonary rehabilitation, t-test, correlation, and
quantitative research methods.
I focused on literature that occurred from 2013 to 2018 for the latest research and
identify current research gaps. When unique and relevant to the study, articles published
from other years were also included. The articles were mostly from peer-reviewed
journals, but whitepapers, books, and CDC website resources were also used.
Theoretical Foundation
The current study was guided by Shearer’s (2009) health empowerment theory.
The health empowerment theory refers to the process of individuals purposefully
participating in changing their environment and self-change, where individuals can
engage the personal, social, and contextual resources available to them and recognize
avenues for the best well-being (Shearer, 2009).
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Origin of the Health Empowerment Theory
The health empowerment theory (Shearer, 2009) emerged as a theory-based
health intervention to help individuals better use the personal, social, and contextual
resources available to them. The original intervention was designed to help older adults
enhance their well-being. This intervention aimed to guide older adults to participate in
their health and treatment actively, to be engaged while attaining health-related goals, and
to foster individual well-being (Shearer, 2009). Shearer (2009) suggested that adults’
health becomes much more complicated as they age, and older adults are vulnerable to
disease and at risk of losing their ability to live independently (Shearer, 2009).
Additionally, older adults are more likely to have multiple health issues and may lack
awareness of their health and their access to personal, social, and contextual resources
(Shearer, 2009).
The health empowerment theory involves three steps: (a) assisting adults to
recognize and increase their self-capacity; (b) increasing adults’ awareness and use of
social support networks; and (c) increasing awareness and use of social services.
Although the health empowerment theory was initially designed for older home-bound
adults with chronic conditions, its uses have expanded to other populations. Awareness,
understanding, engagement, and participation are helpful for all patients; examples are
provided later in this chapter. Figure 1 shows the conceptual model of the health
empowerment theory (Shearer, 2009).
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Figure 1
The Health Empowerment Theory Conceptual Model

Health Empowerment
Intervention:
Personal Resources
Social Contextual Resources

Health Empowerment

Purposeful Participation

Personal Growth

in Goal Attainment

Health Outcome

Self-Acceptance

Awareness

Perceived Well-being

Purpose

Choices
Involvement in Creating

Theoretical Propositions of Health Empowerment Theory
Awareness, understanding, engagement, and participation are critical components
of the health empowerment theory; these involve four main assumptions: (a)
empowerment is an inherent ability of all individuals; (b) empowerment is based on the
relationships between individuals and their environment; (c) empowerment is a
continuous process; and (d) empowerment is expressive of health patterns and well-being
(Shearer, 2009).
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Awareness and Understanding
A significant component of the health empowerment theory is understanding and
awareness of one’s health. This leads to improvements in personal well-being and allows
for more effective healthcare decisions (Shearer, 2009; Watanabe et al., 2015). This
understanding involves both personal resources (e.g., self-capacity) and social resources
(e.g., social support). Importantly, even if an individual has access to sufficient resources,
if they lack the ability to identify and understand these resources, their well-being is
likely to be negatively impacted. In summary, one goal of health empowerment theory is
to help individuals identify their available resources, identify their health goals, and
identify methods to achieve those goals (Shearer, 2009). By increasing awareness and
understanding of one’s resources, health goals, and methods for attaining those goals, as
well as by increasing engagement and ensuring individuals are actively participating in
health-related activities, self-capacity can be increased (Shearer, 2009).
Engagement and Participation
Purposeful engagement and participation are other crucial components of health
empowerment theory (Shearer, 2009). Furthermore, Shearer proposed health
empowerment as a dynamic process that involves being engaged and actively
participating in one’s health by using internal and external resources. Part of fostering
engagement and participation includes reminiscence; this involves asking a patient to
reflect on a time they were able to impact their health and can also help with building
self-capacity (Shearer, 2009). Health empowerment also includes encouraging patients to
reflect on their strengths while acknowledging their weaknesses in a way that turns
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negative characteristics or events into areas for improvement and learning. By actively
participating in self-talk and thought restructuring, patients can think more positively and
are less likely to allow negative thoughts to consume their health actions and decisions
(Shearer, 2009). In summary, purposeful participation and engagement can be dependent
on awareness and intention to change one’s health and health goals (Shearer, 2009).
Previous Use of the Health Empowerment Theory
Many previous scholars have utilized the health empowerment theory (Shearer,
2009) to guide their research (Shearer Fleury et al., 2012; Shin & Park, 2017; Watanabe
et al., 2015). In this section, I discuss previous research using the health empowerment
theory, from well-being, quality of life, and exercise—all of which are critical
components of pulmonary rehabilitation.
Health Empowerment, Well-Being, and Quality of Life
Researchers have emphasized the use of health empowerment theory for
increasing prosperity and quality of life. For instance, this theory was used by Watanabe
et al. (2015) to study the impact of empowerment on community health engagement. This
study involved a qualitative methodology, and results indicated that health empowerment
developed steadily over time as individuals in the community build knowledge and social
resources; then, individuals are more prepared to take action to benefit their health and
well-being. Shearer et al. (2012) conducted a literature review and utilized the health
empowerment theory to examine how older adults make health decisions and outcomes
of interventions in a literature review.
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Grealish et al. (2017) used a cross-sectional research design and an internet based
questionnaire to examine empowerment. A total of 423 individuals aged 16 to 29 years
old participated in this study. Psychological factors, mental well-being, empowerment,
and recovery from personal problems were assessed. Mediation analyses indicated that
empowerment mediates the relationship between psychological factors (psychosocial,
self-efficacy, thinking style, coping, and control) and mental health, well-being, and
recovery from general life problems. Through empowerment, those psychological factors
are related to mental health, well-being, and recovery (Grealish et al., 2017).
Shin and Park (2017) used the health empowerment theory to study how
participation in self-help groups moderated the relationship between empowerment and
quality of life among a sample of breast cancer survivors. The study involved over 250
participants, and overall, the results showed that empowering breast cancer survivors
significantly increased their quality of life. Additionally, self-help group participation had
a significant effect on the breast cancer survivors' feelings of empowerment; this, in turn,
improved their quality of life. The study concluded that by empowering these patients,
which included providing emotional support and information, is critical to the quality of
life, offering support for the health empowerment theory.
Health Empowerment, COPD, and Pulmonary Rehabilitation
Limited research has been conducted on COPD through the health empowerment
theory lens. Fotoukian et al. (2014) conducted a study with a qualitative approach using
content analysis and purposeful sampling to recruit 24 participants. The researchers
collected data by conducting in-depth semi-structured interviews and recording filed
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notes. The researchers found the empowerment of elderly patients with COPD was
affected by many social factors, health care systems, and personal resources, aligning
with the health empowerment theory. Specifically, results indicated empowerment of
elderly patients with COPD was mediated by aging, the nature of COPD,
fear/hopelessness, culture, support systems, economic status, and experience.
Health Empowerment and Exercise
Some previous research has also been conducted on health empowerment and
exercise; this is notable because exercise is a critical piece of COPD treatment and
pulmonary rehabilitation. Park et al. (2015) used a randomized controlled trial design in a
study with 43 Korean older adults with chronic illness, with just over half participating in
the experimental group. The intervention was comprised of two phases: (a) an 8-week
multi-disciplinary, team guided, group-based health education, exercise session, and
individual empowerment counseling; and (b) 16 weeks of self-help group activities,
including weekly exercise and group discussion about maintaining acquired selfmanagement skills and problem-solving skills. The results showed that over time, health
empowerment, physical activity, and physical function in the experimental group
increased significantly compared to the control. The self-management program, which
aligned with health empowerment theory, was shown to improve health, physical activity,
and physical function among the older adults in the sample. The results indicated
empowerment might be an effective method to increase self-control regarding health
behaviors in adults with chronic illness.
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Rationale for Health Empowerment Theory in the Current Study
Research is lacking regarding how the health empowerment theory can be applied
to patients with COPD, specifically those who complete pulmonary rehabilitation.
Through the current study, I aim to increase the understanding of the impacts of
pulmonary rehabilitation and age on COPD readmission rates. Mainly, pulmonary
rehabilitation may be a critical resource for patients with COPD, and awareness and
participation in pulmonary rehabilitation may help to empower them. Furthermore,
patients with COPD could benefit from being aware of pulmonary rehabilitation and how
they can actively participate in their health-related activities and decisions. The results
from this study can help practitioners in determining whether pulmonary rehabilitation
might be more helpful for older patients with COPD.
A summary of the elements of the program theory involved in the health
empowerment theory (Shearer, 2009) are listed below:
•

Problem: a lack of awareness of and engagement in personal, social, and
contextual resources (Shearer, 2009). In my study, the problem is there is a
lack of awareness regarding factors related to the health of patients with
COPD, leading to high readmission rates, which are costly to hospitals and
negatively impact patients.

•

Critical Inputs: these include personal, social, and contextual resources,
including self-capacity, social networks, and service utilization, respectively
(Shearer, 2009). In my study, these include age (personal resource) and
engagement in pulmonary rehabilitation (social/contextual resource).
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•

Mediating Processes: these include health empowerment and purposeful
participation and engagement in goal attainment (Shearer, 2009). In my
study, awareness of the importance of pulmonary rehabilitation and active
participation in one’s health after hospital discharge.

•

Expected Outcomes: thoughts and feelings about one’s well-being (Shearer,
2009). For my study, improved well-being, related explicitly to decreased
COPD-related readmissions rates

•

Exogenous Factors: these include character traits of the patient, setting, and
availability of resources (Shearer, 2009). In my study, comorbid conditions
and possibly other demographics such as gender and race/ethnicity.

•

Implementation Issues: these include materials/resources and
environment/setting (Shearer, 2009). For my study, pulmonary rehabilitation
materials and resources and clinic materials and resources.

Previous researchers have examined readmission rates among patients with
COPD (Amin, 2015; Jiang et al., 2017; Tran et al., 2016; Zhang et al., 2017). Personal
resources (part of health empowerment theory) related to readmission for patients with
COPD include a longer length of stay, older age, comorbidities, and COPD complexity
(Candrilli et al., 2015). Hospitals are also facing challenges regarding harsh financial
penalties resulting from COPD patient readmission (Feemster & Au, 2014; Rinne et al.,
2017). This study aims to help identify protective and risk factors for readmission among
patients with COPD and to evaluate whether there are differences in readmission rates
among patients with COPD who complete at least 30 days of pulmonary rehabilitation
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compared to those who do not. The results from this study can ultimately help inform
hospitals of patients with COPD who might need outpatient treatment or rehabilitation
and avoid monetary fines for readmission.
Literature Review Related to Key Variables
Background of COPD
The CDC (2018) has described COPD as a group of diseases that hinder airflow
and breathing. These include chronic bronchitis and emphysema. These diseases are
treatable, but not curable. Estimates indicate that 16 million Americans currently have
COPD, and millions of others suffer from COPD but have not been formally diagnosed
or treated (CDC, 2018). Symptoms of COPD may include continuous coughing or
wheezing, excessive phlegm or mucus production, shortness of breath, and/or difficulties
taking deep breaths (CDC, 2018).
The CDC (2018) has found tobacco smoke, air pollutants, genetic factors, and
respiratory infections to be some of the leading causes of COPD. There are many
devastating impacts of COPD on one’s life and well-being. For instance, individuals with
COPD may experience difficulty walking, climbing stairs, or exercising; difficulty or
inability to perform at work; a need to use special equipment to treat their disease;
difficulties engaging in social activities; confusion and memory loss; other comorbid
conditions; depression or other mental health problems; and poor health in general (CDC,
2018).
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The Cost of COPD
The Centers for Medicare & Medicaid Services (CMS) implemented the Hospital
Readmission Reduction Program (Lau et al., 2017), which included financial penalties for
COPD readmissions that occur within 30 days of being discharged (Feemster & Au,
2014; Rinne et al., 2017). Currently, in the United States, two million emergency room
(ER) visits are associated with COPD exacerbations with over 700,000 admissions
annually, which totals a cost of $60 billion per year (Feemster & Au, 2014). These
numbers are problematic because over 22% of patients with COPD are readmitted within
30 days of hospital discharge due to COPD-related issues and comorbid conditions
(Crisafulli et al., 2008). Rinne et al. (2017) estimated that hospitals are expected to be
penalized more than $500 million after 2017’s readmission policies. Additional research
is necessary to improve care and reduce readmission rates for patients with COPD after
they are discharged from the hospital (Pruitt, 2018).
Age and COPD
COPD Risk Among the Elderly
Shearer (2009) suggested that adult health becomes much more complicated with
age; therefore, efficient use of personal and social resources is critical. Researchers have
shown that in comparison to younger individuals, older adults are more vulnerable to
disease, at an increased risk of losing their ability to live independently, more likely to
have multiple health issues, and less aware of their health and their access to resources
(Shearer, 2009). Age is especially important regarding COPD, but further research is
needed to better understand the relationship between age and COPD outcomes in the
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United States because results from prior research have shown mixed results. For instance,
the CDC (2018) suggested that adults over the age of 65 are at the highest risk for
developing COPD compared to other ages. In contrast, Ni and Xu (2016) showed that
COPD death rates have increased for women ages 45-64 and over 85 years of age,
compared to other age groups. Other research has been conducted in the United
Kingdom, the results of which indicated that COPD rates, specifically bronchitis, have
declined among adults between 45 and 64 years of age (Pride & Soriano, 2002). More
research is needed to determine whether there is a significant relationship between age
and COPD readmission rates to assess which age groups—if any—may be more
vulnerable.
Empowerment
Empowerment may be a critical component for treatment success for elderly
individuals. Son and Kim (2017) conducted a study with 148 adults with at least one of
the following diseases: hypertension, diabetes, hyperlipidemia, and atherosclerosis. Data
were collected using a structured questionnaire and was analyzed using the independent ttest, Pearson correlation, ANOVA, and hierarchical multiple regression. The researchers
found that health empowerment was significantly correlated with health literacy and
social support. The researchers also found that perceptions of health status and social
activity participation significantly predicted health empowerment. Overall, this study
offers support for health empowerment interventions as a means to improve health
behavior practices of elderly individuals.
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Park and Oh (2017) conducted an experimental study with 76 individuals over the
age of 65 who were registered with home visiting services. A health promotion
empowerment program occurred in the experimental group, which lasted 8 weeks.
Researchers assessed health factors (i.e., health promotion behavior, perceived health
status and frailty) and empowerment factors (i.e., empowerment, social participation).
The results showed the experimental group exhibited improvements in health status,
social participation, and decreased frailty compared to the control group. In summary, the
researchers found the empowerment program was effective for these elderly individuals.
Shin et al. (2016) also conducted an experimental study in Korea, with 41
participants in the experimental group and 36 in the control group. The experimental
group received an empowerment program lasting 12 months. Self-efficacy, social
support, self-care behaviors, blood pressure control, and renal function were assessed.
The results indicated the experimental group had increased self-efficacy and self-care
behavior over time. The experimental group exhibited significant improvement in blood
pressure compared to the control group. The findings of this study also offer support for
the use of empowerment for older individuals.
Sak et al. (2017) studied the roles of psychological empowerment and health
literacy on older individuals’ willingness to participate in treatment and engage in health
decisions. The study was conducted with over 800 Swiss adults between the ages of 65
and 80 years old. This researcher used multivariate logistic regression to identify the
contribution of health literacy, psychological empowerment, and trust in physicians on
participants’ preference to be active, collaborative, or passive in decision-making. Results
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showed that psychological empowerment was significantly correlated with older adults’
preferred and perceived involvement in medical decision-making. Notably, the study also
showed that health literacy mediated the relationship between psychological
empowerment and participant treatment involvement. This study offered support that
providing information and empowering patients is essential, which aligns with the tenets
of health empowerment theory.
Thakur (2017) used the health empowerment theory in a study with elderly
individuals with heart failure who were living at senior centers. The intervention that was
used focused on strategies to identify self-capacity and to increase self-capacity, informed
decision making, goal setting, and social networks. This researcher found the
empowerment program did help to enhance personal growth and purposeful participation
in the attainment of personal health. In summary, this study supports the health
empowerment theory in research with older individuals.
Fotokian et al. (2017) studied the empowerment of individuals with COPD. The
researchers collected data through in-depth semi-structured interviews as well as field
notes; a total of 24 participants were recruited with purposive sampling. The results
indicated that elderly persons with COPD, their family caregivers, and professional team
members engaged in managing life with COPD; striving to keep abreast of life; preparing
for battle with disease; and helping to stabilize the elder’s life.
Managing life with COPD was found to help the elderly patients with COPD feel
in control and live optimally. Notably, the study showed it is critical to understanding the
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experiences of elderly patients with COPD and how empowerment can impact their
health. The study helped healthcare professionals provide more focused elderly care.
In summary, age is the key to understanding health and the impacts of
empowerment. Shearer (2009) suggested that adults’ health becomes much more
complicated as they age; older adults are more vulnerable to disease and more likely to
have multiple health issues compared to younger adults (Shearer, 2009). Further research
is needed to better understand the relationship between age and COPD outcomes in the
United States because results from prior research have shown mixed results (CDC, 2018;
Ni & Xu, 2016; Pride & Soriano, 2002). Empowerment may be a critical component for
treatment success for elderly individuals in the following ways:
•

Son and Kim (2017) found empowerment can improve health behavior
practices;

•

Park and Oh (2017) found the health promotion empowerment program were
effective, particularly for elderly individuals;

•

Shin et al. (2016) found empowerment was effective for rural older adults
with hypertension in South Korea;

•

Sak et al. (2017) found psychological empowerment correlated with older
adults’ preferred and perceived involvement in making health decisions

•

Thakur (2017) conducted an intervention and found empowerment
significantly increased patient’s levels of personal growth and purposeful
health participation.
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•

Fotokian et al. (2017) found empowerment and managing life with COPD was
found to help the elderly patients with COPD feel in control and live
optimally.

COPD and Comorbid Conditions
Researchers have indicated individuals with COPD often have other diagnoses or
health conditions, known as comorbidities (Franssen & Rochester, 2014; Schwab et al.,
2017; Sievi et al., 2015). Patients with underlying health concerns can be problematic
because comorbidities can exacerbate the risk of rehospitalization among patients with
COPD (Schwab et al., 2017). Shah et al. (2016) discussed that 68% of patients with
COPD have at least one comorbid condition, and 16% have two or more comorbid
conditions. Comorbid conditions are important to study and statistically control for in the
current study, as well as in any study involving COPD. The following are examples of
comorbid conditions that individuals with COPD face:
•

Congestive heart failure (Schwab et al., 2017);

•

Coronary artery disease (Schwab et al., 2017);

•

Sleep apnea (Schwab et al., 2017);

•

Cerebrovascular disease (Franssen & Rochester, 2014; Schwab et al., 2017;
Sievi et al., 2015);

•

Depression (Franssen & Rochester, 2014; Schwab et al., 2017; Sievi et al.,
2015), anxiety (Franssen & Rochester, 2014; Schwab et al., 2017; Sievi et al.,
2015), and mental illness (van Eeden et al., 2018);

•

Osteoporosis (Schwab et al., 2017; Sievi et al., 2015);
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•

Type 2 diabetes mellitus (Schwab et al., 2017; Sievi et al., 2015);

•

Lung cancer (Sievi et al., 2015);

•

Hypertension (Sievi et al., 2015);

•

Metabolic syndrome (Franssen & Rochester, 2014; Sievi et al., 2015);

•

Substance abuse disorder (van Eeden et al., 2018);

•

Dysfunctional skeletal myopathies (Franssen & Rochester, 2014; Sievi et al.,
2015); and

•

Cardiovascular diseases (van Eeden et al., 2018).

COPD Readmission Rates
Hospital readmissions are an unfortunately common outcome among patients with
COPD (CDC, 2018; Shah et al., 2015). In this section, the researcher discusses the results
from previous studies pertaining to readmissions rates and reasons for readmission rates
among patients with COPD.
COPD Readmission Rates and Statistics
Shah et al. (2015) performed a large study with over 27 million patients admitted
into the hospital, in which 3.5% had COPD, and these patients were readmitted within 30
days postdischarge with unknown reasoning. Researchers have shown that one in five
patients that are admitted to the hospital for COPD require rehospitalization within 30
days, which is troubling because it increases the economic burden of COPD (Shah et al.,
2016). Although patients with COPD may have other disorders or conditions, researchers
have found that half of the readmissions of patients with COPD are due to respiratory
issues (Shah et al., 2015). Readmissions for patients with COPD are problematic because
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they have been shown to contribute to increased morbidity and mortality (van Eeden et
al., 2018). On the other hand, Shah et al. (2016) suggested that between 10% to 55% of
COPD readmissions are preventable. Future research is needed to identify methods to
prevent readmissions and identify patients who may be more vulnerable to
rehospitalization.
Reasons for COPD Readmissions
Common factors related to readmission for patients with COPD include a longer
length of stay, older age, comorbidity, and COPD complexity (Candrilli et al., 2015; Shah
et al., 2016). Kim et al. (2016) found that there was a significant correlation between
staffing and readmission. Shah et al. (2016) also suggested that due to the length of
recovery time for COPD, it is likely that patients with COPD will need to be hospitalized
within 30 days. Shah et al. conducted a literature review and found that the following
variables are risk factors for early readmissions (readmissions occurring within 30 days
of hospital discharge) for patients with COPD: Black race; comorbidities; congestive
heart failure; frailty; diabetes; psychiatric disorders, such as depression, anxiety,
psychosis, and alcohol or drug use; discharge to post-acute care; dual eligibility for
Medicare and Medicaid; elevated serum arterial blood carbon dioxide level; low BMI;
longer length of hospital stays; and male gender.
Reducing COPD Readmission Rates
Many hospitals lack the required information and methods to reduce COPD
readmissions (Shah et al., 2016). Kim et al. (2016) suggested there is a need to provide
patient education before being discharged from the hospital. Pulmonary rehabilitation
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may offer beneficial treatment options for patients with COPD (Shah et al., 2016). Future
research is needed to understand the impact it has on readmissions. After conducting a
literature review, Shah et al. proposed various possible methods to decrease early (or 30day) readmission rates for patients with COPD, including: patient self-management,
inhaler device training, early outpatient follow-up within 30 days after discharge,
telehealth care, receiving and filling all respiratory medications before being discharged,
pharmacist-supervised medication reconciliation, medications, and pulmonary
rehabilitation.
Summary of COPD Literature
COPD refers to a group of diseases that restrict and hinder airflow, including
bronchitis and emphysema (CDC, 2018). It is hypothesized that tobacco smoke, air
pollutants, genetic factors, and respiratory infections are some of the leading causes of
COPD (CDC, 2018). Older adults are more vulnerable to disease and at risk of losing
their ability to live independently compared to younger adults (Shearer, 2009); however,
research regarding age and COPD readmissions has yielded mixed results. Previous
studies have shown that individuals with COPD often have other diagnoses or health
conditions (Franssen & Rochester, 2014; Schwab et al., 2017; Sievi et al., 2015),
including coronary artery disease, mental health conditions, osteoporosis, hypertension,
and Type 2 diabetes. These and other comorbid conditions may exacerbate readmissions
rates.
Up to 20% of patients with COPD are hospitalized within 30 days of being
discharged; many cases are preventable (Shah et al., 2016). Other reasons for
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readmissions (other than comorbid conditions) include, but are not limited to, being
African American, male, exhibiting dual eligibility for Medicare and Medicaid, and a low
BMI (Shah et al., 2016). There has been research completed addressing ways to reduce
the likelihood of COPD readmission; these include training on inhalers, early follow-up,
telehealth care, and medications. Another promising intervention for treating COPD is
pulmonary rehabilitation. In the following section, the researcher describes pulmonary
rehabilitation and its potential to treat COPD and decrease COPD readmission rates.
The Background of Pulmonary Rehabilitation
Pulmonary rehabilitation, also known as respiratory rehabilitation, is a suggested
treatment for COPD, along with other treatments such as smoking cessation, medications,
and the use of supplemental oxygen (CDC, 2018). Pulmonary rehabilitation treatments
are tailored to individual patients to help teach COPD management strategies that can
ultimately help improve the quality of life. Part of this treatment includes teaching
patients how to conserve their energy, engage in better breathing strategies, and
increase/improve eating and exercise habits (CDC, 2018). Notably, the American
Association of Respiratory Care (AARC, 2007) and CDC (2018) indicated a benefit of
pulmonary rehabilitation is that it can be conducted in different treatment
environments/settings and is designed uniquely for each patient.
Pulmonary rehabilitation treatment involves many components. Supervised
exercise training is the major component; however, many other components can help
manage and reduce COPD symptoms (Hill et al., 2013). Other elements of pulmonary
rehabilitation include smoking cessation, pharmacotherapy, early identification and
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treatment of acute exacerbations, management of acute dyspnea, physical activity,
improvement of body composition, promotion of mental health awareness, advance care
planning, and creation of social networks (Hill et al., 2013).
Benefits of Pulmonary Rehabilitation
Pulmonary rehabilitation has been shown to improve exercise performance,
functional status, health status, and healthcare use among patients with COPD (Shah et
al., 2016). In this section, the researcher outlines the significant benefits of pulmonary
rehabilitation, including decreases in the likelihood of readmission, patient
empowerment, and decreased fatigue and improvements on the BODE index. Notably,
these benefits may help patients with COPD reduce their risk of future hospital
readmissions.
Readmissions
There are many benefits of pulmonary rehabilitation. For instance, Alshabanat et
al. (2017) developed a COPD management plan, which was implemented and shown to
improve hospitalizations by 30% and decrease readmissions. Kargiannakis et al. (2017)
utilized telehealth medicine to patients discharged from the hospital with a COPD
exacerbation. This intervention was useful as it reduced readmissions from the standard
of 20% down to 9% (Kargiannakis et al., 2017). Bhatt et al. (2018) studied a form of
pulmonary rehabilitation referred to as telehealth pulmonary rehabilitation and found that
compared to a control group, patients with COPD who received the exercise intervention
had lower readmission rates. A gap in the literature remains regarding pulmonary
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rehabilitation’s impact on patients with COPD and other factors that may impact
readmissions rates.
Ko et al. (2018) conducted a randomized controlled trial to examine the impact of
pulmonary rehabilitation on patient readmissions. Patients in the invention group
received four to eight sessions of 2-hour outpatient physiotherapy training, one to two
times each week; each participant in the experimental group would have at least 4 to 8
weeks of supervised training by a trained physiotherapist. Patients in the intervention
group were contacted by the case manager every 2 weeks, by phone, to provide support
and reinforcement for continuous exercise at home for 1 year. The control group received
care as they would usually, without a physiotherapist or case manager intervention. Over
130 individuals participated in the study, where activity was measured through activity
monitors. The results indicated the readmission rate for individuals in the control group
was significantly higher at 12 months compared to the individuals in the experimental
group. Notably, after 12 months, there was no change in the steps per day (measured by
the activity tracker) in the experimental versus the control group. The results were that
individuals in the control group had a shorter period between discharge and readmission,
meaning they were being readmitted sooner than individuals in the experimental group.
Overall, this study offers support for the use of short-course pulmonary rehabilitation to
decrease the number of readmissions and lengthen the time between readmissions.
Maddocks et al. (2015) conducted a literature review to examine the impact of
pulmonary rehabilitation programs on readmissions rates for patients with COPD. These
researchers found that most randomized controlled trials showed exercise-based
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interventions, such as pulmonary rehabilitation, can improve exercise capacity, improve
health-related quality of life, reduce healthcare utilization, and reduce readmissions. The
researchers cautioned that the results from these particular and controlled trials might not
generalize to all healthcare settings. This study still offers support for the use of
pulmonary rehabilitation as a potentially useful method for increasing health and
reducing readmission rates.
Rajput and Banerjee (2017) conducted a study to examine the impact of
pulmonary rehabilitation. A total of 60 patients with COPD were randomly selected for
inclusion in the study; 30 had completed pulmonary rehabilitation, and 30 had not. The
primary outcome variable assessed in the study were hospital readmissions rate at 12
months, and the baseline data were similar for both groups. Overall, results showed
pulmonary rehabilitation could reduce readmissions and mortality in patients with COPD.
The researchers found that the patients that completed pulmonary rehabilitation showed a
more significant improvement in the walking test compared to the patients that did not
complete pulmonary rehabilitation. In addition, the patients that completed pulmonary
rehabilitation showed a more significant improvement in their stress scores compared to
patients that did not complete pulmonary rehabilitation. The patients that completed
pulmonary rehabilitation showed a more significant improvement in their depression
scores compared to those that did not complete pulmonary rehabilitation. Lastly, at 12
months, the readmission rate was significantly lower for patients that complete
pulmonary rehabilitation compared to those that did not (1.5 to 5.2, respectively); of the
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patients that completed pulmonary rehabilitation, zero died, whereas 15 of the patients
that did not complete pulmonary rehabilitation died (Rajput & Banerjee, 2017).
Patient Empowerment
Importantly, pulmonary rehabilitation may help to empower patients. For
instance, pulmonary rehabilitation helps to increase self-management and behavior
change (Bourbeau et al., 2018). Fotokian et al. (2017) conducted a qualitative study and
found the ability of older patients to manage their life with COPD enables them to feel in
control and live optimally. This study also showed that understanding the experiences of
the empowerment process of elderly patients with COPD can help health professionals
provide more focused elderly care (Fotokian et al., 2017).
Meis et al. (2014) linked pulmonary rehabilitation to autonomy, which is also
linked to patient empowerment. Focus groups and semi-structured interviews were
conducted; data were collected from seven patients with COPD before completing a
pulmonary rehabilitation program, but data from only six patients were collected after
pulmonary rehabilitation. The researchers also conducted focus groups and semistructured interviews with 14 healthcare workers. Qualitative data analysis involved a
phenomenological approach. The following themes were apparent:
•

Before pulmonary rehabilitation, patients expressed challenges in accepting
their COPD diagnosis;

•

Before pulmonary rehabilitation, patients had insufficient knowledge of
COPD;
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•

Before pulmonary rehabilitation, patients had difficulty with setting realistic
goals;

•

Support from others and healthcare workers helped patients with COPD
overcome challenges;

•

After beginning pulmonary rehabilitation, the patients with COPD showed
increases in confidence to exercise and manage their daily activities;

•

Patients with COPD expressed a desire to have control over their lives;

•

Healthcare professionals played a vital role in guiding patients with COPD
through pulmonary rehabilitation; and

•

Overall, pulmonary rehabilitation provided a personalized approach to
treatment for patients with COPD by offering tailored advice, autonomysupportive counseling, self-management skills, and referrals to local exercise
facilities (Meis et al., 2014).

Decreased Fatigue
Pulmonary rehabilitation has also been linked to reduced fatigue. For instance,
Farias et al. (2014) conducted an experimental study where participants completed an
experimental study where 40 patients with COPD were assigned to participate in an 8week pulmonary rehabilitation (n=20) or a control group (n=20). The researchers found
those patients that received pulmonary rehabilitation experienced less fatigue and feelings
of dyspnea (Farias et al., 2014).
McCarthy et al. (2015) also studied pulmonary rehabilitation’s impact on fatigue.
Results offered support for pulmonary rehabilitation as a critical component in managing
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COPD, improving health-related quality of life, and increased exercise. These researchers
found that pulmonary rehabilitation significantly reduced dyspnea and fatigue. The
researchers noted future research on pulmonary rehabilitation is needed to understand its
effectiveness.
Other research by Lewko et al. (2014) examined the impacts of pulmonary
rehabilitation on fatigue. A total of 37 patients participated in this study; 23 of these
patients completed pulmonary rehabilitation, and the remainder did not. Researchers
collected data using the Multidimensional Fatigue Inventory, Quality of Life
Questionnaire, Anxiety and Depression (HADS) measure, the London Chest Activity of
Daily Living Scale (LCADL), muscle strength test, and incremental (ISWT) and
endurance (ESWT) shuttle walk tests. Data analysis involved the Wilcoxon test and
Spearman correlation. The results indicated that after pulmonary rehabilitation, there
were statistically significant improvements in reduced activity, general fatigue, physical
fatigue, ISWT/ESWT, and muscle strength (Lewko et al., 2014). Lewko et al. identified
no statistically significant difference in motivation or mental fatigue scores between
patients who completed pulmonary rehabilitation compared to those who did not. Impacts
on fatigue may only apply to physical fatigue; furthermore, the effects of pulmonary
rehabilitation may not always be apparent, and further research is necessary in additional
settings to determine its effectiveness.
Improvements in the BODE Index
The BODE index is a mortality index that includes measures of body-mass index,
airflow obstruction, dyspnea, and exercise capacity. (Farias et al., 2014). Farias et al.
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found that patients with COPD who completed an 8-week pulmonary rehabilitation
program showed improvements in the BODE index compared to COPD patients in the
control group. A total of 34 COPD patients participated in the study and were assigned to
a control group and an intervention group (that received pulmonary rehabilitation). The
researchers assessed the following variables: pulmonary function, distance covered
during the 6-minute walk test (6MWT), respiratory strength, peripheral muscle strength,
health-related quality of life (HRQOL), body composition, and level of activities of daily
living (Farias et al., 2014). The results indicated the intervention group exhibited
improvements in the 6MWT, decreases in sensation of dyspnea and fatigue, increases in
work performed, improvements on the BODE index, improvements on the HRQOL,
increases in ADL level, and increases in lower limb strength (p<0.05). The researchers
also found it was more cost-effective for patients who received pulmonary rehabilitation.
This study showed that, among patients with COPD, physical activity in pulmonary
rehabilitation leads to clinical benefits in a cost-effective manner (Farias et al., 2014).
Benavides and Wilches (2017) conducted a study evaluating 8 weeks of
pulmonary rehabilitation. These researchers used a descriptive, retrospective-longitudinal
study. A total of 24 patients were selected for inclusion in the study. The researchers
gathered data from a hospital from 2009-2010 for these patients. Information records
filled out in the years 2009-2010 were selected. Data were analyzed using descriptive
analysis, which included frequencies, measures of central tendency, and plots of the
distributions. The results indicated that the estimated 4-year survival significantly
increased from 55.17% to 71.83% after pulmonary rehabilitation. In addition, the total
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score on the BODE index, the exercise tolerance score, the walk test score, and the
dyspnea score all significantly improved after pulmonary rehabilitation (Benavides &
Wilches, 2017).
Güell et al. (2017) examined whether pulmonary rehabilitation benefits decrease
over time, gradually, for patients with COPD. The researchers tested whether a long-term
(3-year) maintenance program given to patients with COPD after pulmonary
rehabilitation preserves the short-term benefits for patients with COPD. The randomized
trial involved over 140 patients with moderate to severe COPD. Patients in the
intervention group received 3 years of maintenance after completing an 8-week
pulmonary rehabilitation program. Patients in the control group were assigned to receive
a standard monitoring program or control group. The researchers assessed the programs’
effects on the BODE index, the 6-minute-walk test distance (6MWD), and the healthrelated quality of life score (Güell et al., 2017).
Patients’ scores were assessed at 12, 24, and 36 months (Güell et al., 2017). A
total of 138 (96.5%) completed the 8-week program. For all participants, after the 8-week
pulmonary rehabilitation program alone, health-related quality of life was significantly
improved. During the follow-up maintenance period, the intervention group exhibited a
more significant increase in the 6MWD compared to the control group, and the gradual
decline in the 6MWD occurred more slowly in the intervention group compared to the
control group. The adherence rate for the control group was significantly higher than the
control group, with rates of 66% and 17%, respectively. Overall, the study showed
pulmonary rehabilitation is effective for short-term impacts and the follow-up program
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helped to maintain those benefits pertaining to the scores on the BODE index and 6MWD
(Güell et al., 2017).
Perhar et al. (2015) also examined pulmonary rehabilitation’s impact on the
BODE index. The researchers used an experimental design, and a total of 60 patients
participated in the study; all participants had moderate to severe COPD diagnoses. The 30
patients in the control group received treatment for COPD, and the 30 patients in the
experimental group received treatment for COPD and pulmonary rehabilitation. The
researchers collected data through the BODE index. Overall, the results showed that
pulmonary rehabilitation participation by COPD patients improved BODE index scores.
More specifically, the results indicated that the experimental group exhibited significant
improvement on the BODE index from the time of diagnosis until the first week of
pulmonary rehabilitation. In addition, the experimental group exhibited significant
improvement on the BODE index from the first week through the sixth week of
pulmonary rehabilitation. Finally, the experimental group exhibited significant
improvement on the BODE index from the time of diagnosis till the sixth week of
pulmonary rehabilitation.
Summary of Pulmonary Rehabilitation Literature
In summary, pulmonary rehabilitation is a respiratory treatment for COPD
tailored to each patient (CDC, 2018). Hill et al. (2013) noted there are various essential
components of pulmonary rehabilitation, including exercise training, smoking cessation,
and pharmacotherapy. Early identification and treatment of acute exacerbations help
manage the following; acute dyspnea; physical activity; improvement of body
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composition; promotion of mental health awareness; advance care planning; and creation
of social networks (Hill et al., 2013). Pulmonary rehabilitation can lead to many benefits
for patients with COPD; these benefits include decreases in the likelihood of readmission,
patient empowerment, decreased fatigue, and improvements on the BODE index.
Importantly, these benefits of pulmonary rehabilitation may help patients with COPD
reduce their risk of future hospital readmissions. In the following sections of Chapter 2,
the researcher describes and evaluates the research methods of previous studies;
afterward, the research gap and aim of the current study are discussed.
Critique of Previous Research Methods
Research is lacking concerning quantitative studies comparing pulmonary
rehabilitation participants’ readmissions rates to readmissions rates of patients who do
not complete pulmonary rehabilitation in the United States. It is also critical research is
conducted to control for potential confounding variables and examine the relationship
between age and readmission rates for patients with COPD. In this section, the researcher
critiques the research methods used in studies that are similar to the two research
questions of the current study.
Studies Regarding Pulmonary Rehabilitation and COPD Readmission Rate
Many studies pertaining to pulmonary rehabilitation’s impact on COPD
readmissions rates have involved experimental designs (e.g., Garvey, 2015), and
literature reviews (e.g., Maddocks et al., 2015; Shah et al., 2016). Some studies support
the idea that pulmonary rehabilitation can positively influence readmission rates
(Alshabanat et al., 2017; Garvey, 2015; Kargiannakis et al., 2017; Ko et al., 2018;
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Maddocks et al., 2015). Other researchers have offered contradictory findings; for
instance, pulmonary rehabilitation may only be effective when started soon after hospital
discharge, and possibly may not be significantly effective at all (Lee, 2005). Some have
indicated that standard pulmonary rehabilitation without RMT does not impact the
readmission rates of patients with COPD (PN Medical, 2016). Further research is needed
using a quantitative methodology and controlling for potential confounds such as the
presence of comorbid conditions and time between discharge and the start of pulmonary
rehabilitation.
Studies Regarding Age and COPD Readmission Rates
Previous research pertaining to age and COPD readmission rates have shown
mixed results. For instance, the CDC (2018) suggested that adults over the age of 65 are
at the highest risk for developing COPD compared to other ages. Ni and Xu (2016)
showed that COPD death rates have increased for women aged 45-64 years, as well as for
those over 85 years of age. Other research has been conducted in the United Kingdom,
the results of which indicated that COPD rates, specifically bronchitis, has declined
among adults between 45 and 64 years of age (Pride & Soriano, 2002). Future research is
needed in the United States to determine whether there is a significant relationship
between age and COPD readmission rates to determine ages that may be more
vulnerable. Empowerment may be a critical component for treatment success for elderly
individuals (Son & Kim, 2017); therefore, it is crucial that future researchers examine
COPD through the lens of health empowerment theory.
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The Research Gap and Significance of the Current Study
Researchers have stated that hospitals have little guidance when it comes to
implementing practices and strategies to reduce COPD readmissions, and it is pertinent
that future research examines the correlation of COPD readmissions with the benefits of
pulmonary rehabilitation (Shah et al., 2016). The lack of understanding around factors
impacting COPD readmissions, among pulmonary rehabilitation patients, is significant
because COPD is a leading cause of both hospitalizations and readmissions in the United
States (Baker et al., 2013). Furthermore, pulmonary rehabilitation is a widely used
method of treatment for patients with COPD (e.g., Apps et al., 2016; Rochester et al.,
2015).
This research study regarding readmission rates of patients with COPD is
necessary because readmissions of patients with COPD can be costly to the hospitals and
indicate poor health of the patient. Pruitt (2018) discusses the loss of CMS
reimbursement as a result of COPD readmissions, which can then negatively impact
hospitals, particularly those with narrow profit margins. There is a need to improve care
and reduce readmission (Pruitt, 2018); studying readmission for patients with COPD is
particularly important because patients with COPD tend to have comorbid conditions
(Crisafulli et al., 2008). For instance, in one study, the researchers found that over half
(51%) of patients with COPD who were going through pulmonary rehabilitation had at
least one other chronic disease; metabolic diseases and heart diseases were the two most
common comorbidities (Crisafulli et al., 2008). Some previous researchers have
supported the notion that pulmonary rehabilitation helps decrease readmission rates
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(Alshabanat et al., 2017; Garvey, 2015; Kargiannakis et al., 2017; Ko et al., 2018;
Maddocks et al., 2015), whereas other studies do not (Lee, 2005; PN Medical, 2016).
Quantitative research that controls for potential confounds such as the presence of
comorbid conditions, gender, etc., is needed.
Furthermore, the lack of understanding regarding factors impacting COPD
readmissions among pulmonary rehabilitation patients is significant because COPD is a
leading cause of both hospitalizations and hospital readmissions in the United States
(Baker et al., 2013). Importantly, researchers have indicated there is a lack of research
pertaining to the impact of empowerment on healthcare and health issues (Jacquinet et
al., 2018); through this study, the researcher aimed to fill part of this gap by examining
the health of patients with COPD from the United States, from the health empowerment
theory perspective. Researchers have also found that increasing knowledge of and access
to pulmonary rehabilitation is important for patients, physicians, and insurance
companies (Rochester et al., 2015).
This study was guided by the health empowerment theory (Shearer, 2009).
Additional research regarding the health empowerment of patients with COPD is critical,
as pulmonary rehabilitation may be a crucial resource for patients with COPD, and
awareness and participation in pulmonary rehabilitation may help to empower them.
Furthermore, patients with COPD could benefit from being made aware of pulmonary
rehabilitation and how they can actively participate in their own health-related activities
and decisions. The results from this study assist practitioners in determining whether
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pulmonary rehabilitation might be more helpful for older patients with COPD if age and
COPD readmission rates are significantly correlated.
Summary and Conclusions
I used Google Scholar, PubMed, and ERIC to identify previous studies regarding
key variables and concepts in this study for the literature review; search terms were both
broad and narrow to capture enough information for the literature review. The current
study was guided by Shearer’s (2009) health empowerment theory, which initially
emerged as a theory-based health intervention to help individuals better use the personal,
social, and contextual resources available to them (Shearer, 2009). The health
empowerment theory involves assisting adults in recognizing and increasing their selfcapacity, increasing adults’ awareness use of social support networks, and increasing
awareness and use of social services. This theory assumes that empowerment is an
inherent ability; based on the relationships between individuals and their environment, a
continuous process, and expressive of health patterns (Shearer, 2009).
A significant component of the health empowerment theory is understanding and
awareness of one’s own health could lead to improvements in well-being and allow for
more effective health care decisions (Shearer, 2009; Watanabe et al., 2015). Purposeful
engagement and participation are additional crucial components of health empowerment
theory (Shearer, 2009). Many other studies have utilized the health empowerment theory
(Shearer, 2009) to guide their research (Shearer Fleury et al., 2012; Shin & Park, 2017;
Watanabe et al., 2015); these topics include research pertaining to health empowerment,
well-being, and quality of life (e.g., Grealish et al., 2017; Watanabe et al., 2015); health
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empowerment, COPD, and pulmonary rehabilitation (e.g., Fotoukian et al., 2014); and
health empowerment and exercise (e.g., Park et al., 2015).
The CDC (2018) describes COPD as a group of diseases that hinder airflow and
breathing, which affects approximately 16 million individuals in the United States.
Individuals with COPD face many obstacles, including, but not limited to, difficulty
walking, work performance issues, confusion and memory loss, other comorbid
conditions, and poor health (CDC, 2018). Notably, COPD is very costly to hospitals and
society in general. Age is key to understanding health and the impacts of empowerment.
Shearer (2009) suggested that adults’ health becomes much more complicated as they
age; older adults are more vulnerable to disease and more likely to have multiple health
issues compared to younger adults (Shearer, 2009). Empowerment may be a critical
component for treatment success for elderly individuals.
Unfortunately, individuals with COPD often have other diagnoses or health
conditions (Franssen & Rochester, 2014; Schwab et al., 2017; Sievi et al., 2015),
including—but not limited to—coronary heart disease, mental health disorders,
hypertension, and cardiovascular disease. Furthermore, patients with COPD have a high
likelihood of readmissions (CDC, 2018; Shah et al., 2015). Some of the key reasons for
readmission include a long length of initial hospital stay, being male and African
American, and having comorbid conditions such as diabetes. Pulmonary rehabilitation
may offer beneficial treatment options for patients with COPD (Shah et al., 2016). Future
research is needed to understand its impact.
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Pulmonary rehabilitation treatment involves many components. Supervised
exercise training is one major component; however, other components can help patients
with COPD manage and reduce symptoms (Hill et al., 2013). These additional
components include smoking cessation, advance care planning, creation of social
networks, and more (Hill et al., 2013). Pulmonary rehabilitation has been shown to
improve exercise performance, functional status, health status, and health-care use among
patients with COPD (Shah et al., 2016). Research suggests pulmonary rehabilitation may
help reduce readmissions rates (e.g., Ko et al., 2018), increase patient empowerment
(e.g., Bourbeau et al., 2018), decrease fatigue (e.g., McCarthy et al., 2015), and improve
performance on the BODE index (e.g., Farias et al., 2014).
Researchers have stated that hospitals have little guidance when it comes to
implementing practices and strategies to reduce COPD readmissions and it is pertinent
that future research examines the correlation of COPD readmissions, and the benefits of
pulmonary rehabilitation (Shah et al., 2016). Currently, the literature is lacking
quantitative studies involving patients with COPD from the United States in pulmonary
rehabilitation that controls for potential confounds. In the current study, the researcher
assessed the benefits of pulmonary rehabilitation on hospital readmissions for patients
with COPD in one facility. Specifically, the researcher identified whether there is a
statistically significant difference between readmission rates of patients with COPD who
participate in 30 days of pulmonary rehabilitation compared to those who do not
complete any pulmonary rehabilitation, after adjusting for potential confounders. The
researcher also examined whether there is a relationship between age and 30-day

53
readmission rates for patients admitted with COPD, after adjusting for potential
confounders. In the next chapter, I discuss the study’s design and rationale, methodology
(including information on the population and sampling), and procedures for recruitment,
participation, and data collection. Statistical analyses and ethical procedures are also
described.
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Chapter 3: Research Methods
Introduction
Through this quantitative study, I evaluated the benefits of pulmonary
rehabilitation on hospital readmissions for patients with COPD. Specifically, the
dependent variable of readmissions was investigated in relation to the predictor variables
of participation in a 6-week pulmonary rehabilitation program and the age of COPD
patients. The purpose of this study was to determine whether the completion of a 6-week
pulmonary rehabilitation program impacts the outcomes of care for patients with COPD,
measured by hospital readmission. This study included the exploration of demographic
factors that may impact the hospital readmission of patients with COPD to determine
whether hospital readmission for COPD patients differs based on demographics and how
results associated with a 6-week pulmonary rehabilitation program may differ based on
demographics. This chapter includes of a description of the study’s research design,
methodology, and data analysis plan, potential threats to validity, and ethical
considerations.
Research Design and Rationale
In this section, I discuss the selected research design and the rationale for this
selection. This section is organized into the following subsections: research design, study
variables, and potential constraints.
Research Design
I employed a quantitative cross-sectional design. The cross-sectional design was
selected for use in the current study because the participants in cross-sectional study
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designs are selected based on the criteria set for the research, rather than based on the
outcome or exposure status (Setia, 2016). In the current study, the selection criteria
included patients from McLaren Lapeer, a clinic in Michigan, that were diagnosed with
COPD. Cross-sectional studies are also used to investigate diseases in clinic-based
samples (Setia, 2016). In the current study, a clinic sample was used.
I employed multiple linear regression because this type of analysis provides a
model to determine the relations between two or more predictor variables (i.e.,
independent variables) and a response variable (i.e., dependent variable; Alexopoulos,
2010; StatSoft, 2013). The purpose of this study was to determine the relationship
between hospital readmissions for patients with COPD as a response variable in relation
to the predictor variables of the completion of a 6-week pulmonary rehabilitation
program and demographic variables. In the subsections to follow, the dependent and
independent variables are described, followed by a presentation of the constraints of this
study.
Variables
In the current study, the dependent variable was readmissions for patients with
COPD, which the researcher measured in rates. The predictor variables in this study
included a categorical variable, which was participation in a 6-week pulmonary
rehabilitation program, and a continuous variable, which was age of patients with COPD.
I used statistics to examine group differences and relationships, and the variables were
continuous and numeric, both of which are hallmarks of the quantitative methodology.
For this to occur, I compared 30-day readmissions for patients with COPD who complete
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at least 6 weeks of pulmonary rehabilitation program to the readmissions of those who do
not complete a pulmonary rehabilitation program; 6 weeks was chosen because it takes at
least 6 weeks to exhibit changes in well-being (Shearer, 2009). Age and other relevant
demographics, such as gender, weight, and BMI, were included in the analysis to
determine whether they had any impact on the likelihood of readmission. A description of
these variables is included in Table 1 below.
Table 1
Variable Descriptions
Variable
Dependent Variable
30-day hospital
readmission
Independent Variables
Participation in a 6-week
pulmonary rehabilitation
program
Age
Sex
Weight
BMI

Variable Type and Range
Discrete [0…30]
Categorical [Yes/No]
Continuous [x …. x]
Categorical [Male/Female]
Continuous [x….x]
Categorical [up to 18.5/18.5 – 24.9/25.0 –
29.9/30.0 and above]

Potential Constraints
There were no anticipated time constraints, other than completing this study
within the timeframe for graduation. Resource constraints included a lack of access to
COPD client data from a variety of clinics for comparison; this limitation is further
discussed in Chapter 5. For this reason, only one clinic in Northern Michigan was
selected as the population of study. There were, therefore, limitations associated with the
generalizability of the results generated from this study. The constraint of access to
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COPD client data was reduced by using only one in Northern Michigan as the target
population.
Methodology
Population
The target population included all patients with COPD that went to McLaren
Lapeer Regional Medical Center, a clinic in Michigan, between the years 2017 and 2019.
The target population included both male and female patients between 48 and 90 years
old. The total number of patients with COPD in the clinic of study was 218, as this study
was conducted in a single facility. After obtaining permission from McLaren Lapeer
Medical Center and Walden University’s Institutional Review Board (IRB), I collected
deidentified, secondary data of all patients with COPD from McLaren Lapeer Medical
Center. The sample population and procedures are further described in the following
section.
Sampling and Sampling Procedures
This target population included 154 patients with COPD, 77 of which participated
in pulmonary rehabilitation and 77 of which did not. Convenience and purposive
sampling were used in the current study because the data available to the researcher were
from one nearby clinic; only patients with a diagnosis of COPD were considered in this
study. The sample size selected for this study was determined and supported with a
power analysis conducted to calculate the required sample size based on the parameters
for this study. The sampling and sampling procedures are further described below. The
researcher first obtained approval from McLaren Lapeer to conduct the study; afterward,
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the researcher gained approval from Walden University’s IRB (approval number: 05-2220-0602321). I did not work directly with any of the patients, and the data were
anonymous. McLaren Lapeer provided the data without me ever meeting with
participants. The inclusion criteria involved patients with a clinical diagnosis of COPD;
half had participated in pulmonary rehabilitation, and half did not participate in
pulmonary rehabilitation. Exclusion criteria included not expressing consent for me to
use patient data, not having completed at least 30 days of pulmonary rehabilitation
criteria, and not having been in posthospital treatment at the clinic for at least 30 days.
I conducted an a priori power analysis in G*Power to determine the required
minimum sample size for the study. Four factors were considered in the power analysis:
significance level, effect size, the power of the test, and statistical technique. The
significance level, also known as Type I error, refers to the chance of rejecting a null
hypothesis given that it is true (Creswell & Poth, 2017). Most quantitative studies make
use of a 95% confidence level because it adequately provides enough statistical evidence
of a test (Creswell & Poth, 2017). The effect size refers to the estimated measurement of
the relationship between the variables being considered (Cohen, 1988). Cohen
categorized effect size into small, medium, and large; a medium effect size strikes a
balance between being too strict (small) and too lenient (large). The power of test refers
to the probability of correctly rejecting a null hypothesis (Sullivan & Feinn, 2012). In
most quantitative studies, 80% power is usually used (Sullivan & Feinn, 2012). I used
G*Power to calculate the minimum sample size (Appendix A). When using hierarchical
regression, in order to detect a medium effect size of f2 = 0.15 at a 5% level of
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significance, with 80% power, a minimum sample size of at least 55 participants is
required. A sample of 128, therefore, would cover both minimum size requirements. To
compensate for any cases that may be removed due to data cleaning, missing information,
or outliers, a 20% increase was applied to the minimum sample size of 128. Thus, 26
additional individuals were sampled, bringing the minimum sample size to 154.
Procedures for Recruitment, Participation, and Data Collection
Participants for this study were not recruited; rather, I collected deidentified,
secondary data from the McLaren Lapeer clinic in Michigan. Data included patient
demographics, such as gender, age, race/ethnicity, in addition to patient participation in a
pulmonary rehabilitation program, patient participation in a pulmonary rehabilitation
program for at least 6 weeks, 30-day patient readmission rates, and cause for patient
readmission. McLaren Lapeer did not share patient names or identifying information with
me. The clinic in Michigan provided data on demographics and pulmonary rehabilitation
completion to me through a password-protected Excel file. The data were then stored on
a password-protected computer only available to me. I will delete the data file 7 years
after the research is completed, and there will not be a follow-up to this study. For the
duration of the 7-year period in which the data are retained, the data will be stored on a
password-protected computer only available to me.
Instrumentation and Operationalization of Constructs
No instruments were used in this study. The predictor and criterion variables of
this study, as well as demographics, were collected from the treatment clinic, as they

60
routinely collect this data for all of their patients. This study did not include any research
instruments; therefore, there are no estimates of reliability and validity.
Data Analysis Plan
The data analysis first involved the cleaning of the data that has been collected,
including the identification of any outliers or inconsistent data. All of the data were
provided from McLaren Lapeer through a password-protected Excel file. I stored this file
on a password-protected computer. I cleaned the data, which involved looking for data
that seems erroneous (with values that do not apply) or missing data. I communicated
with the clinic regarding any errors or missing data using Excel. The data from the Excel
file were imported into SPSS to clean and troubleshoot the data and for statistical
analyses. Following the cleaning of the data and import of the data into SPSS, basic
descriptive statistics were generated, including the means, frequencies, and trends in the
data. Descriptive analyses were also conducted to define the average, standard deviation,
and ranges of the independent and dependent variables in this study. The data were
examined to determine whether they met the assumptions of normality by conducting
tests of normality and plotting the distributions of the variables in SPSS. I conducted
statistical analyses to answer the following research questions:
Research Question 1: Is there a difference between readmission rates of patients
with COPD who participate in 6 weeks of pulmonary rehabilitation compared to those
who do not?
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H10: There is no difference in the readmission rates of patients with COPD who
participate in at least 6 weeks of pulmonary rehabilitation compared to those who
do not.
H1a: There is a difference in the readmission rates of patients with COPD who
participate in at least 6 weeks of pulmonary rehabilitation compared to those who
do not.
Research Question 2: Is there a relationship between age and 30-day readmission
rates for patients admitted with COPD?
H20: There is no relationship between age and 30-day readmission rates for
patients admitted with COPD.
H2a: There is a relationship between age and 30-day readmission rates for patients
admitted with COPD.
I conducted a simple linear regression analysis to determine the differences in
readmission rates for patients with COPD that participate in at least 6 weeks of
pulmonary rehabilitation versus patients with COPD that do not. A simple linear
regression was on the outcome and each independent variable. Simple linear regression
was used to test Research Question 1 regarding whether there are differences in COPD
readmissions rates for patients that completed 6 weeks of pulmonary rehabilitation
compared to those who did not. Simple linear regression was also used to test Research
Question 2 regarding whether there is a significant predictive relationship between
patient age and COPD readmissions rates. Lastly, I conducted a multiple linear regression
to consider potential confounding variables and to determine the relationship between the
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dependent variable and all independent variables. Multiple linear regression was used to
enter demographic variables such as gender and comorbid disorders into the model to
determine whether they impact COPD readmissions rates. Multiple linear regression was
also used to explore adjusted odds ratios (ORs) and to answer the research questions
more thoroughly. In the review of all statistical analyses, particularly in the simple linear
regression and multiple linear regression, a p-value of <0.05 was used to determine
statistical significance. Linear regression and multiple linear regression were appropriate
based on the research questions, the continuous nature of the criterion variable, and the
continuous and categorical predictor variables.
Threats to Validity
I did not anticipate any threats to external validity, internal validity, or construct
validity because no instruments were utilized in this study. The variables involved in this
study were strictly monitored by the clinic for all patients; therefore, the likelihood of
error was low.
Ethical Procedures
I did not anticipate any ethical concerns for participants. Before collecting any
data, I obtained written permission from McLaren Lapeer and the Walden University
IRB. Informed consent was not needed in this study because I collected secondary data
from the clinic, and no names or identifying information were used. There were no
anticipated ethical concerns regarding recruitment or data collection procedures.

63
Summary
Through this quantitative study, I assessed the benefits of pulmonary
rehabilitation on hospital readmissions for patients with COPD. Specifically, I
determined whether there is a difference in readmission rates for patients with COPD
who complete at least 6 weeks of pulmonary rehabilitation compared to those who do not
complete any pulmonary rehabilitation. Additionally, I determined whether there is a
significant relationship between age and readmission rates. The predictor variables in this
study included participation—or lack thereof—in a 6-week pulmonary rehabilitation
program and the age of COPD patients; 6 weeks was chosen because changes in wellbeing are estimated to emerge after 6 weeks (Shearer, 2009). The criterion variable
included readmission rates for COPD patients. I obtained approval from McLaren Lapeer
and the Walden University IRB before conducting this study and did not anticipate any
ethical concerns because the data were anonymous and only accessible to me.
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Chapter 4: Results
Introduction
The purpose of this quantitative study was to examine the benefits of pulmonary
rehabilitation on hospital readmissions for COPD patients. To do this, I compared 30-day
readmissions for COPD patients who completed a pulmonary rehabilitation program to
the readmissions of those who did not complete a pulmonary rehabilitation program.
Furthermore, because age may impact treatment and care received (Candrilli et al., 2015),
I also examined whether age was significantly related to hospital readmission for COPD
patients in one COPD facility. I statistically controlled for the demographic variables of
sex and BMI..
Research Questions and Hypotheses
In this study, I focused on key variables related to readmissions for COPD
patients. The research questions and hypotheses that guided this study were:
RQ1: Is there a difference between readmission rates of patients with COPD who
participate in 6 weeks of pulmonary rehabilitation compared to those who do not?
H10: There is no difference in the readmission rates of patients with COPD who
participate in at least 6 weeks of pulmonary rehabilitation compared to those who
do not.
H1a: There is a difference in the readmission rates of patients with COPD who
participate in at least 6 weeks of pulmonary rehabilitation compared to those who
do not.
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RQ2: Is there a relationship between age and 30-day readmission rates for patients
admitted with COPD?
H20: There is no relationship between age and 30-day readmission rates for
patients admitted with COPD.
H2a: There is a relationship between age and 30-day readmission rates for patients
admitted with COPD.
To answer the questions and test the hypotheses, I employed a quantitative research
design and conducted linear regression analysis to test whether the independent variables
were related to the dependent variables, while controlling for demographic variables. In
this chapter, I present the descriptive statistics of the variables of interest and examines
the data and test of assumptions for all variables. Next, I present the results from the
linear regressions. A summary of the results concludes the chapter.
Data Collection
I collected the data used for this study from McLaren Lapeer clinic between 2017
and 2019. Due to the collection of secondary hospital data, no recruitment methods were
used during this study. The targeted population included any patients with COPD who
went to McLaren Lapeer Medical Center, a clinic in Michigan, between the years 2017
and 2019. Data were collected from 253 patients with COPD. This met the criteria for the
minimum sample requirements to detect an effect, because the sample was greater than
128. Specifically, the final sample for this study included 51 COPD patients who
participated in pulmonary rehabilitation and 202 COPD patients who did not participate
in pulmonary rehabilitation.
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Results
Descriptive Statistics
The participants included 253 patients with COPD who went to McLaren Lapeer
Medical Center, a clinic in Michigan, between years 2017 and 2019. Of this sample, 44
had readmission rates greater than the targeted 30 days, leaving a final sample of 209
(21.5% completed 6 weeks of pulmonary rehabilitation). In the sample, 53.1% were
female and 46.9% were male. For BMI, 12 (5.7%) patients had a BMI less than 18.50,
while 82 (39.2%) patients had a BMI of 30 or above. In addition, about 12% of the
sample were readmitted within 30 days. Table 2 below presents the characteristics of the
sample. The average days to readmission for the total sample was 1.86 (SD = 5.72).
Assessing only those who were readmitted, the average days to readmission was 15.52
(SD = 7.92).
Table 2
Descriptive Statistics for the Continuous Dependent and Independent Variables
Variable
Readmission (Total Sample)
30-day Readmitted Patients
Age (Years)
BMI (kg/m2)
Testing Assumptions

N
209
25
209
209

Mean
1.86
15.52
69.70
29.28

Std. Deviation Minimum Maximum
5.72
0.000
30.00
7.92
3.00
30.00
9.45
47.00
96.00
8.24
15.40
58.70

I answered the research questions using linear regression analysis. There are four
assumptions of linear regression: normality, homoscedasticity, independence, and
linearity (Cohen et al., 2003). There was only one predictor variable in the simple linear
regression models; therefore, the assumptions of multicollinearity and independence were
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met. Multicollinearity and independence for the multiple regression model are discussed
below. To examine normality of the dependent variables, I examined the histogram and
P-P plot for readmission rate (see Figure 2). Figure 2 illustrates that the readmission rate
was positively skewed, and the Shapiro-Wilks was also significant (W = .37, p < .001),
suggesting nonnormality. A logarithm transformation (log10) of the data did not reveal a
normally distributed dependent variable. Thus, I concluded that logarithmic
transformation was inappropriate for the present analysis.
Figure 2
Histogram and P-P Plot for Readmission Rate
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To test the assumption of multicollinearity, I tested the variance inflation factor
(VIF) amongst the independent variables in the multiple regression model. A VIF value
greater than 10 suggests a violation of multicollinearity (Cohen et al., 2003). The VIF
values ranged from 1.003 to 1.034. Thus, I concluded that the assumption of
multicollinearity was met.
To test the assumption of independence, I evaluated the Durbin-Watson value for
the residuals for the independent variables. The Durbin-Watson value was 1.41, which is
within the range for acceptability (values should be close to 2; see Cohen et al., 2003).
Based on these results, I determined that the assumption of independence was met.
To test the assumption of linearity, I examined scatterplots of the continuous
independent variable (Age) against Readmission Rate (Log Transformed). The scatterplot
did not follow a linear pattern (see Figure 3); therefore, the assumption of linearity was
not met.
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Figure 3
Scatterplots for Linearity Test of Assumption for Age

Given the lack of normality and linearity for the independent and dependent variables, I
selected robust linear regression to analyze the data, as this method is designed to
overcome violations of assumptions and are not sensitive to outliers (Andersen, 2008).
Simple Linear Regression
First, each independent variable was evaluated separately on readmission rates.
To investigate whether sex predicts the readmission rates of COPD patients, I conducted
a simple linear regression with readmission rates as the dependent variable and sex as the
independent variable. The results of the linear regression were not significant, at F(1,
207) = 1.141 and p = .287, with an 𝑅" of 0.005. This indicates that sex (B = -.847, p =
.287) did not contribute significantly to the model.

70
To investigate whether age predicts the readmission rates of COPD patients, I
conducted a simple linear regression with readmission rates as the dependent variable and
age as the independent variable. The results of the linear regression were not significant,
at F(1, 207) = 1.966 and p = .162, with an 𝑅" of 0.009. This indicates that age (B = .059,
p = .162) did not contribute significantly to the model.
To investigate whether BMI predicts the readmission rates of COPD patients, I
conducted a simple linear regression with readmission rates as the dependent variable and
BMI as the independent variable. The results of the linear regression were not significant,
at F(1, 207) = .028 and p = .867, with an 𝑅" of 0.000. This indicates that BMI (B = -.008,
p = .867) did not contribute significantly to the model.
To investigate whether 6 weeks of pulmonary rehabilitation predicts the
readmission rates of COPD patients, I conducted a simple linear regression with
readmission rates as the dependent variable and pulmonary rehabilitation as the
independent variable. The results of the linear regression were not significant, at F(1,
207) = 0.002 and p = .964, with an 𝑅" of 0.000. This indicates that pulmonary
rehabilitation (B = -.044, p = .964) did not contribute significantly to the model. Table 3
summarizes the results of the simple linear regressions.
Table 3
Summary of Simple Linear Regressions with Independent Variables Predicting
Readmission Rates of COPD Patients
Variable
(Constant)
Sex
(Constant)
Age

B
2.306
-.847
-2.234
.059

SE
.578
.793
2.944
.042

b
-.074
.097

t
3.992
-1.068
-.759
1.402

p
.000
.287
.449
.162
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(Constant)
BMI
(Constant)
Pulmonary Rehabilitation

2.094
-.008
1.866
-.044

1.468
.048
.448
.965

-.012
-.003

1.427
-.168
4.167
-.045

.155
.867
.000
.964

Multiple Linear Regression
Next, I conducted a two-step hierarchical multiple regression to evaluate whether
age and 6 weeks of pulmonary rehabilitation predicted readmission rates of COPD
patients, while controlling for sex and BMI. In Step 1 of the model, I conducted the
multiple regression with sex and BMI as covariates and readmission rates of COPD
patients as the dependent variable. The results of the regression for Step 1 indicated that
the model was not significant for sex and BMI on readmission rates of COPD patients, at
F(2, 206) = .574 and p = .564, with an 𝑅" of 0.006.
In Step 2, I determined that adding age and pulmonary rehabilitation to the
regression model explained an additional 0.3% of variance in readmission rates of COPD
patients; however, the change in 𝑅" was not significant, at Fchange(2, 204) = 0.983 and p
=.376. The overall omnibus test for the Model in Step 2 was also not significant, at F(4,
204) = .778 and p = .540, with an 𝑅" of .015, suggesting that the final model was not
significantly different than 0. This suggests that the data analysis did not support age or
pulmonary rehabilitation to predict readmission rates of COPD patients after controlling
for demographic and personal factors (sex and BMI). Table 4 summarizes the results of
the hierarchical multiple regression model.
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Table 4
Summary of Hierarchal Multiple Regression for Variables Predicting Readmission Rates
of COPD Patients
Variable
(Constant)
Sex
BMI
Age
Pulmonary
Rehabilitation
R"
F for Change in R"
*p < .05. **p < .01

B
2.461
-.842
-.005

Model 1
SE
1.508
.796
.048

b
-.074
-.008

B
-1.938
-.837
.004
.060
-.223

.006

Model 2
SE
3.515
.796
.049
.043
.978
.015
.983

b
-.073
.005
.099
-.016

Summary
In this chapter, I presented the results after testing the central hypothesis of this
study, which was that age and pulmonary rehabilitation would influence the readmission
rates of COPD patients. The results of the data analysis did not support age or pulmonary
rehabilitation to predict readmission rates of COPD patients. In addition, I concluded that
demographic and personal factors (i.e., sex and BMI) did not influence the rate of
readmission of COPD patients. In Chapter 5, I provide a detailed summary of the analysis
results, discusses the potential contributions of this study, and presents theoretical and
practical implications, limitations, and future directions based on the findings.
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Chapter 5: Discussion, Conclusions, and Recommendations
Introduction
The purpose of this quantitative study was to examine the benefits of pulmonary
rehabilitation on hospital readmissions for COPD patients. To achieve this, I compared
30-day readmissions for COPD patients who completed a pulmonary rehabilitation
program to the readmissions of those who did not complete a pulmonary rehabilitation
program. I included age and other relevant demographics—such as gender, weight, and
BMI—in the analysis to determine the likelihood of readmission. Pulmonary
rehabilitation is designed to improve the physical and psychological conditions of people
with chronic respiratory disease and can involve exercise training, education, and
behavior changes (Man et al., 2015). Pulmonary rehabilitation is only offered to a small
amount of COPD patients and may or may not be a key component of readmissions
(Casaburi, 2018). The lack of rehabilitation options proves to be problematic as
pulmonary rehabilitation may be influential in decreasing readmissions (Alshabanat et al.,
2017). COPD readmissions can be expensive for the hospital and can decrease patient
health (Crisafulli et al., 2008; Pruitt, 2018). In this chapter, I interpret the findings by
comparing them to the conclusions outlined in the previous body of literature.
Interpretation of the Findings
Before analysis of Research Question 1, I performed a simple linear regression
analysis of BMI readmission rates of COPD patients to understand whether individual
factors influenced the rate of readmission for COPD patients. From this analysis, I found
that BMI was not significantly associated with COPD readmissions.
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The first research question asked whether there was a difference between
readmission rates of patients with COPD who participated in 6 weeks of pulmonary
rehabilitation compared to those who did not. The results of the analysis were that there
was no statistically significant relationship between the two groups. The existing
literature highlighted the importance of COPD treatment in reducing readmissions,
thereby the results of this study differ from previous findings. Previously, Rajput and
Banerjee (2017) and Lewko et al. (2014) supported the importance of pulmonary
rehabilitation. Rehabilitation treatments such as pharmacotherapy, physical activity,
improvement of body compensation, and advanced care planning should all be beneficial
to reducing readmissions for a COPD patient (Farias et al., 2014; Hill et al., 2013;
McCarthy et al., 2015). The results of Research Question 1 in this study indicated no
significant association between pulmonary rehabilitation and COPD readmissions. It is
unknown whether a specific type of pulmonary rehabilitation may have changed the
results, but as a whole, rehabilitation did not influence COPD readmission.
Research Question 2 asked whether there was a relationship between age and 30day readmission rates for patients admitted with COPD. I determined that there was not a
statistically significant relationship between age and 30-day readmission rates for patients
with COPD. These data allow for acceptance of the null hypothesis in this study. In the
literature reviewed in Chapter 2, I identified that some researchers had found a significant
relationship between age and COPD. When focusing on age and COPD, Shearer (2009)
indicated that adult health becomes more complicated as one gets older because the
elderly are more prone to vulnerable diseases, have a decreased ability to live
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independently, have coexisting health issues, and are less aware of their medical
resources. The CDC (2018) stated that those over the age of 65 years have the highest
risk for COPD and readmissions, in comparison to other age groups. However, this
investigation did not find a relationship between age and readmission rates. Because the
literature is undecided on the importance of pulmonary rehabilitation to COPD
readmissions, the importance of addressing the role of pulmonary rehabilitation as it
relates to hospital readmission remains.
The mixed findings from the literature, when compared to the findings of this
study, indicate that pulmonary rehabilitation may have no influence on COPD and that
age is also a questionable variable when it comes to readmission rate. The results of the
current study, therefore, indicate that age nor BMI should be a priority for COPD
treatment to reduce readmissions. Additionally, less emphasis should be placed on
pulmonary rehabilitation as a whole assessing reduction in COPD readmissions. Instead,
other variables that have not been examined within this study may have a greater
influence on COPD readmissions.
Limitations
There were numerous limitations for the study. The first limitation was my
selection of a nonexperimental design, limiting his ability to make casual claims
(Blundell & Costa Dias, 2000). Additionally, this study was quantitative instead of
qualitative. A qualitative design could have offered insight into patients’ or doctors’
views into health empowerment and COPD treatment along with readmission rates.
Another limitation was the geographic range; the data were gathered and collected from
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one site, meaning that transferability to other hospitals may be limited. This offers the
opportunity for future researchers to compare results between locations. Lastly, the
variables selected from the study may have limited the results of the study. By including
other variables such as other medical conditions, pre-existing conditions, and treatment
options, the findings of the research may have changed.
Recommendations
The first recommendation for future research would be to change the
methodology from quantitative to mixed-methods. A mixed-methods approach to the
study opens up new research avenues, such as the use of health empowerment theory to
understand the thoughts and feelings of the participants regarding COPD recovery and
readmissions. When dealing with the participants own opinion/perspective, there is a
potential for bias. An additional option for future research would be a take the study to
multiple hospitals in various geographic areas. Urban areas may have different results
than rural; therefore, it is important to understand these differences. Furthermore, by
expanding the scope of the research, scholars could evaluate the transferability of the
study findings between areas.
The discrepancies between previous scholarly findings and this study’s results,
and the lack of certain variables in the body of literature, also present opportunities for
further investigation. The first pathway for future research would be to study the
variables not necessarily covered in the literature. Variables such as BMI and gender had
minimal references in the literature review. Extending the literature research for age and
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BMI might shed light on the phenomenon. It would also be beneficial to compare the
results of this study and other existing ones.
One variable not included within the study was underlying health conditions.
COPD is affected by other diseases (Shearer, 2009). Another variable to be studied is
whether patients practice the doctors’ instructions upon discharge. Studying self-efficacy,
family support, and following the doctor’s orders could all offer an opportunity to shine
further light on the health problem.
Implications
Positive Social Change
While there were no statistically significant relationships between the selected
variables, there are implications for positive social change at the individual,
organizational, and theoretical level. At the individual level, the first suggestion is to limit
the use of 6 weeks of pulmonary rehabilitation for COPD and focus on other treatments.
As mentioned in the literature review, it is imperative to practice a high degree of selfefficiency when dealing with this disease. The literature contained information expanding
patient knowledge to help limit readmission rates. Additionally, following exercises and
doctor’s orders could also reduce COPD readmission. Age should also not be considered
when prioritizing patients with COPD. Instead, doctors should look at other co-variates to
determine the proper course of action.
Due to the lack of statistical significance for both questions, there are some
implications at the organizational level. Health organizations such as hospitals should
invest less money into pulmonary rehabilitation programs and should instead focus on
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imparting health knowledge to the patient upon discharge. By reducing investments into
COPD rehabilitation, this money could support the implementation of other, more proven
methods, thereby lowering health costs. Previous researchers have indicated that an
increase of knowledge and self-efficiency help decrease readmission rates; therefore, it is
the doctor’s prerogative to impart the necessary knowledge and information to the patient
to help reduce the chances of readmission. Health organizations should also focus on the
severity of the disease itself and not prioritize those of greater age.
Theoretical Implications
Health empowerment theory was strongly supported by the literature; however, it
was a difficult fit to link them to the results of this study. It was uncovered that through
health empowerment theory, patients should maintain knowledge of COPD, follow the
doctor’s orders, practice self-efficiency, and have caregiver support to reduce 30-day
admissions. Health empowerment theory largely came into play to determine whether
there is a difference between readmission rates of patients who participated in 6 weeks of
pulmonary rehabilitation and those who did not. While there was no significant
relationship, the theory aligned with the literature about treatment options which could
improve health conditions and reduce readmissions. Health empowerment theory,
therefore, should not be limited within the confined treatment of this study and instead be
used with other treatments.
Conclusion
Through this study, I aimed to investigate the benefits of pulmonary rehabilitation
on hospital readmissions for COPD patients in one facility. Currently, the existing
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literature is lacking quantitative studies involving patients with COPD from the United
States in pulmonary rehabilitation that controls for multiple variables. Future researchers
could benefit by a change to a mixed methods approach to utilize health empowerment
theory to understand the perceptions of the patients’ time in COPD recovery. By focusing
on the participants’ perceptions along with hard data, positive and negative behaviors
may be determined. While I did not identify any statistically significant relationships, I
suggest several opportunities for positive social change, such as an investment into other
more proven methods of COPD treatment. Despite the lack of statistical significance, the
results provide actionable insights to improve the treatment of COPD patients.
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Appendix A: Power Calculations for Minimum Sample Size

ANCOVA
F tests - ANCOVA: Fixed effects, main effects and interactions
Analysis:

A priori: Compute required sample size

Input:

Effect size f

= 0.25

α err prob

= 0.05

Power (1-β err prob)

= .80

Numerator df

= 1

Number of groups

= 2

Number of covariates

= 4

Noncentrality parameter λ

= 8.0000000

Critical F

= 3.9188157

Denominator df

= 122

Total sample size

= 128

Actual power

= 0.8012613

Output:

Hierarchical Regression
F tests - Linear multiple regression: Fixed model, R² increase
Analysis:

A priori: Compute required sample size

Input:

Effect size f²

= 0.15

α err prob

= 0.05

Power (1-β err prob)

= .80

Number of tested predictors

= 1

Total number of predictors

= 5

Noncentrality parameter λ

= 8.2500000

Critical F

= 4.0383926

Numerator df

= 1

Denominator df

= 49

Total sample size

= 55

Actual power

= 0.8038932

Output:

